Article
Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
Pharmacogenetics and genomics - 1 Dec 2011
Taja-Chayeb Lucia, González-Fierro Aurora, Miguez-Muñoz Cristian, Trejo-Becerril Catalina, Cruz-Hernandez Erick de la, Cantu David, Agundez Jose A, Vidal-Millan Silvia, Gutierrez Olga, Dueñas-González Alfonso
Abstract excerpt
N-acetyltransferase 2 (NAT2) catalyzes the bioactivation and/or detoxification of drugs and carcinogens. The aim of this study was to establish the correlation between the NAT2 genotype and the acetylating phenotype in a Mexican population using sulfamethazine as a probe. From a total of 122 individuals, 73 (59.8%) were slow and 49 (40.2%) were fast acetylators. Eleven individuals (9%) had the wild-type genotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
